132 related articles for article (PubMed ID: 7979954)
1. A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients.
Babineau TJ; Hackford A; Kenler A; Bistrian B; Forse RA; Fairchild PG; Heard S; Keroack M; Caushaj P; Benotti P
Arch Surg; 1994 Nov; 129(11):1204-10. PubMed ID: 7979954
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients.
Babineau TJ; Marcello P; Swails W; Kenler A; Bistrian B; Forse RA
Ann Surg; 1994 Nov; 220(5):601-9. PubMed ID: 7979607
[TBL] [Abstract][Full Text] [Related]
3. Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group.
Dellinger EP; Babineau TJ; Bleicher P; Kaiser AB; Seibert GB; Postier RG; Vogel SB; Norman J; Kaufman D; Galandiuk S; Condon RE
Arch Surg; 1999 Sep; 134(9):977-83. PubMed ID: 10487593
[TBL] [Abstract][Full Text] [Related]
4. PGG-glucan, a leukocyte-specific immunostimulant, does not potentiate GVHD or allograft rejection.
Washburn WK; Otsu I; Gottschalk R; Monaco AP
J Surg Res; 1996 May; 62(2):179-83. PubMed ID: 8632636
[TBL] [Abstract][Full Text] [Related]
5. Synergism between poly-(1-6)-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea pig model.
Kaiser AB; Kernodle DS
Antimicrob Agents Chemother; 1998 Sep; 42(9):2449-51. PubMed ID: 9736583
[TBL] [Abstract][Full Text] [Related]
6. Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice.
Niederman R; Kelderman H; Socransky S; Ostroff G; Genco C; Kent R; Stashenko P
Arch Oral Biol; 2002 Aug; 47(8):613-8. PubMed ID: 12221019
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic anti-infective activity of poly-[1-6]-beta-D-glucopyranosyl-[1-3]-beta-D-glucopryanose glucan in a guinea pig model of staphylococcal wound infection.
Kernodle DS; Gates H; Kaiser AB
Antimicrob Agents Chemother; 1998 Mar; 42(3):545-9. PubMed ID: 9517930
[TBL] [Abstract][Full Text] [Related]
8. Improved antimicrobial host defense in mice following poly-(1,6)-β-D-glucopyranosyl-(1,3)-β-D-glucopyranose glucan treatment by a gender-dependent immune mechanism.
Newsome CT; Flores E; Ayala A; Gregory S; Reichner JS
Clin Vaccine Immunol; 2011 Dec; 18(12):2043-9. PubMed ID: 21976224
[TBL] [Abstract][Full Text] [Related]
9. Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3-1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects.
Halstenson CE; Shamp T; Gargano MA; Walsh RM; Patchen ML
Invest New Drugs; 2016 Apr; 34(2):202-15. PubMed ID: 26865390
[TBL] [Abstract][Full Text] [Related]
10. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ
Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896
[TBL] [Abstract][Full Text] [Related]
11. PGG-Glucan activates NF-kappaB-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line.
Adams DS; Pero SC; Petro JB; Nathans R; Mackin WM; Wakshull E
J Leukoc Biol; 1997 Dec; 62(6):865-73. PubMed ID: 9400829
[TBL] [Abstract][Full Text] [Related]
12. Passive transfer of poly-(1-6)-beta-glucotriosyl-(1-3)-beta-glucopyranose glucan protection against lethal infection in an animal model of intra-abdominal sepsis.
Cisneros RL; Gibson FC; Tzianabos AO
Infect Immun; 1996 Jun; 64(6):2201-5. PubMed ID: 8675327
[TBL] [Abstract][Full Text] [Related]
13. Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan).
de Felippe Júnior J; da Rocha e Silva Júnior M; Maciel FM; Soares Ade M; Mendes NF
Surg Gynecol Obstet; 1993 Oct; 177(4):383-8. PubMed ID: 8211583
[TBL] [Abstract][Full Text] [Related]
14. PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor.
Wakshull E; Brunke-Reese D; Lindermuth J; Fisette L; Nathans RS; Crowley JJ; Tufts JC; Zimmerman J; Mackin W; Adams DS
Immunopharmacology; 1999 Feb; 41(2):89-107. PubMed ID: 10102791
[TBL] [Abstract][Full Text] [Related]
15. A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal Cancer.
Segal NH; Gada P; Senzer N; Gargano MA; Patchen ML; Saltz LB
Clin Colorectal Cancer; 2016 Sep; 15(3):222-7. PubMed ID: 26975418
[TBL] [Abstract][Full Text] [Related]
16. Reduction of infection-stimulated periapical bone resorption by the biological response modifier PGG glucan.
Stashenko P; Wang CY; Riley E; Wu Y; Ostroff G; Niederman R
J Dent Res; 1995 Jan; 74(1):323-30. PubMed ID: 7876425
[TBL] [Abstract][Full Text] [Related]
17. A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes.
Zimmerman JW; Lindermuth J; Fish PA; Palace GP; Stevenson TT; DeMong DE
J Biol Chem; 1998 Aug; 273(34):22014-20. PubMed ID: 9705343
[TBL] [Abstract][Full Text] [Related]
18. Activation of rat macrophages by Betafectin PGG-glucan requires cross-linking of membrane receptors distinct from complement receptor three (CR3).
Michalek M; Melican D; Brunke-Reese D; Langevin M; Lemerise K; Galbraith W; Patchen M; Mackin W
J Leukoc Biol; 1998 Sep; 64(3):337-44. PubMed ID: 9738660
[TBL] [Abstract][Full Text] [Related]
19. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity.
Liang J; Melican D; Cafro L; Palace G; Fisette L; Armstrong R; Patchen ML
Int J Immunopharmacol; 1998 Nov; 20(11):595-614. PubMed ID: 9848393
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis with the immunomodulator PGG glucan enhances antibiotic efficacy in rats infected with antibiotic-resistant bacteria.
Tzianabos AO; Cisneros RL
Ann N Y Acad Sci; 1996 Oct; 797():285-7. PubMed ID: 8993382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
